Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Neglected Tropical Disease Treatment Market Outlook

The global neglected tropical disease treatment market is expected to grow at a CAGR of 6% over the forecast period of 2024-2032.

Global Neglected Tropical Disease Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

It is expected that the initiatives undertaken by several organisations worldwide to raise understanding and access to medicines for neglected tropical diseases will fuel the growth of the global neglected tropical disease treatment market. The growing prevalence of neglected tropical diseases has given rise to awareness-raising and the increased investment in the R&D sector to develop drugs for its treatment.

Market Segmentation

Neglected tropical diseases are a group of tropical infections, which are widespread in low-income communities, particularly in developing regions like Africa and Asia. These are caused by a variety of pathogens, including viruses, bacteria, protozoa, and helminths.

Global Neglected Tropical Disease Treatment Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The global neglected tropical disease treatment industry can be divided based on segments like types and regions.

The industry can be broadly categorised based on its types into:

  • Antiparasitic Drugs
  • Antibacterial Drugs
  • Antiviral Drugs

The EMR report looks into the regional neglected tropical disease treatment markets like North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa.

Global Neglected Tropical Disease Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

Some of the root causes of neglected tropical diseases are the lack of proper hygiene, the lack of basic services such as clean water, and inadequate steps to prevent diseases. The governments across the nations are taking concerted measures to reduce the spread of neglected tropical diseases. India's Stop Dengue campaign aims to reduce dengue-related mortality and morbidity in the country by motivating people to adopt better health practices. In addition, organisations such as WHO are supporting the nation by providing free bed nets to reduce the number of malaria cases. These factors are expected to support the development of the global market for neglected tropical disease treatment in the future.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global neglected tropical disease treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Region
Breakup by Type
  • Antiparasitic Drugs
  • Antibacterial Drugs
  • Antiviral Drugs
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 6% between 2023 and 2032.

The major drivers of the industry include government intervention for hygiene and monetary and non-monetary help from major international non-governmental organisations like the WHO.

The rising awareness-raising and the increased investment in the R&D sector is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The types of neglected tropical disease treatment available are antiparasitic drugs, antibacterial drugs, and antiviral drugs.

The leading players in this market are Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., amongst others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124